Results for tag: "Neuroinflammation"

Neuroinflammation is a condition in which the body's immune system responds to damage or injury to the nervous system. It is a major factor in the development of many neurological disorders, including multiple sclerosis, Alzheimer's disease, Parkinson's disease, and stroke. Neuroinflammation is characterized by the activation of glial cells, which are the immune cells of the central nervous system. These cells produce inflammatory molecules, such as cytokines, which can cause damage to the neurons and other cells in the brain. The neuroinflammation market is a rapidly growing segment of the neurology industry. It is driven by the increasing prevalence of neurological disorders, as well as the development of new treatments and therapies. Companies in this market are focused on developing drugs and therapies that target the underlying causes of neuroinflammation, as well as those that can reduce its symptoms. Some of the major companies in the neuroinflammation market include AbbVie, Biogen, Merck, Novartis, Pfizer, and Sanofi. These companies are developing a range of treatments, including biologics, small molecules, and immunotherapies, to address the underlying causes of neuroinflammation. Show Less Read more